7.47 USD
↘ 0.04 (0.54%)PRE MARKET (AS OF 07:58 AM EDT)
Arcturus Therapeutics Holdings Inc. Common Stock
ARCTNASDAQ • USD
Market: OPEN
Open?$7.53
High?$7.53
Low?$7.43
Prev. Close?$7.47
Volume?929
Avg. Volume?405.5K
VWAP?$7.49
Rel. Volume?0.00x
Bid / Ask
Bid?$6.46 × 100
Ask?$8.54 × 100
Spread?$2.08
Midpoint?$7.50
Valuation & Ratios
Market Cap?212.3M
Shares Out?28.4M
Float?23.8M
Float %?83.6%
P/E Ratio?N/A
P/B Ratio?1.11
EPS?-$2.77
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.
Themes
Employees
111
Market Cap
212.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2013-05-22
Address
10285 SCIENCE CENTER DRIVE
SAN DIEGO, CA
Phone: (858) 900-2660
SAN DIEGO, CA
Phone: (858) 900-2660
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?6.31Strong
Quick Ratio?6.31Strong
Cash Ratio?6.15Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score92/100
P/E?N/A▾
P/B?1.11CHEAP▾
P/S?3.88FAIR▾
P/FCF?N/A▾
EV/EBITDA?-0.0CHEAP▾
EV/Sales?0.02CHEAP▾
Returns & Efficiency
ROE?-41.1%WEAK▾
ROA?-32.1%WEAK▾
Cash Flow & Enterprise
FCF?$-58667000
Enterprise Value?$945.3K
Fundamentals ratios updated end of day